CMPX
Price
$0.80
Change
-$0.01 (-1.23%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
146.68M
13 days until earnings call
Intraday BUY SELL Signals
MIRM
Price
$83.10
Change
-$0.34 (-0.41%)
Updated
Oct 22 closing price
Capitalization
5.42B
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CMPX vs MIRM

CMPX vs MIRM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CMPX vs. MIRM commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMPX is a Buy and MIRM is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CMPX with price predictions
Oct 21, 2026

CMPX in +4.63% Uptrend, advancing for three consecutive days on October 15, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CMPX advanced for three days, in 232 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for CMPX just turned positive on October 09, 2026. Looking at past instances where CMPX's MACD turned positive, the stock continued to rise in 38 of 46 cases over the following month. The odds of a continued upward trend are 83%.

CMPX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CMPX as a result. In 77 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CMPX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

The Aroon Indicator for CMPX entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.883) is normal, around the industry mean (2.988). P/E Ratio (-2.088) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (555.556) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. CMPX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CMPX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for MIRM with price predictions
Oct 21, 2026

MIRM in upward trend: price may jump up because it broke its lower Bollinger Band on September 18, 2026

MIRM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 34 of 37 cases where MIRM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MIRM's RSI Oscillator exited the oversold zone, 11 of 13 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 60 of 67 cases where MIRM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on MIRM as a result. In 85 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.

The Moving Average Convergence Divergence (MACD) for MIRM just turned positive on October 12, 2026. Looking at past instances where MIRM's MACD turned positive, the stock continued to rise in 38 of 47 cases over the following month. The odds of a continued upward trend are 81%.

Following a +6.15% 3-day Advance, the price is estimated to grow further. Considering data from situations where MIRM advanced for three days, in 235 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

Bearish Trend Analysis

The 50-day moving average for MIRM moved below the 200-day moving average on October 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIRM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

The Aroon Indicator for MIRM entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MIRM's P/B Ratio (-519.856) is very low in comparison to the industry average of (2.988). P/E Ratio (-5.926) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (8.842) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 37 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. MIRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
MIRM: Fundamental Ratings
MIRM
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
37
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
17
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMPXMIRM
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 17 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
64%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (CMPX: $0.81 vs. MIRM: $83.44)
Brand notoriety: CMPX and MIRM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMPX: 31% vs. MIRM: 80%
Market capitalization -- CMPX: $144.34M vs. MIRM: $5.4B
CMPX [@Biotechnology] is valued at $144.34M. MIRM’s [@Biotechnology] market capitalization is $5.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMPX’s FA Score shows that 1 FA rating(s) are green while MIRM’s FA Score has 2 green FA rating(s).

  • CMPX’s FA Score: 1 green, 4 red.
  • MIRM’s FA Score: 2 green, 3 red.
According to our system of comparison, MIRM is a better buy in the long-term than CMPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMPX’s TA Score shows that 5 TA indicator(s) are bullish while MIRM’s TA Score has 6 bullish TA indicator(s).

  • CMPX’s TA Score: 5 bullish, 3 bearish.
  • MIRM’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, MIRM is a better buy in the short-term than CMPX.

Price Growth

CMPX (@Biotechnology) experienced а -7.34% price change this week, while MIRM (@Biotechnology) price change was +4.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

CMPX is expected to report earnings on Nov 04, 2026.

MIRM is expected to report earnings on Nov 03, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CMPX
Daily Signal:
Gain/Loss:
MIRM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with VCYT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
-2.26%
VCYT - CMPX
37%
Loosely correlated
+3.19%
SMMT - CMPX
35%
Loosely correlated
-1.62%
MIRM - CMPX
34%
Loosely correlated
-1.92%
VIR - CMPX
34%
Loosely correlated
-1.58%
XNCR - CMPX
34%
Loosely correlated
+0.88%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CGV15.940.12
+0.73%
Conductor Global Equity Value ETF (CGV)
MDYG104.800.62
+0.60%
State Street SPDR S&P 400 Mid Cap Growth ETF (MDYG)
CBTY22.46N/A
N/A
Calamos Bitcoin 80 Series Structured Alt Protection ETF - July (CBTY)
EZA65.32-0.12
-0.18%
iShares MSCI South Africa ETF (EZA)
NVOX9.88-0.14
-1.40%
Defiance Daily Target 2X Long NVO ETF (NVOX)